Anavex Life Sciences (AVXL) Return on Capital Employed (2017 - 2022)

Anavex Life Sciences (AVXL) has 6 years of Return on Capital Employed data on file, last reported at 61.67% in Q2 2022.

• For the quarter ending Q2 2022, Return on Capital Employed changed N/A year-over-year to 61.67%; the trailing twelve-month figure through Jun 2022 stood at 61.67% (changed N/A YoY), and the FY2021 full-year result was 48.12%, up 8925.0% from the prior year.
• Return on Capital Employed slipped to 61.67% in Q2 2022, from 199.69% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 295.19% in Q3 2021 to a low of 102.44% in Q1 2019.
• A 5-year average of 39.64% and a median of 38.74% in 2018 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed slumped 5913 bps in 2019 and jumped 28285 bps in 2021, its largest moves.
• Tracing AVXL's Return on Capital Employed over 5 years: stood at 78.66% in 2018, then jumped by 40 bps to 46.85% in 2019, then surged by 285 bps to 86.45% in 2020, then jumped by 232 bps to 286.93% in 2021, then slumped by 79 bps to 61.67% in 2022.
• Business Quant data shows AVXL's Return on Capital Employed at 61.67% in Q2 2022, 199.69% in Q1 2022, and 286.93% in Q4 2021.